Valo Health Raises $300 million Series B
Valo Health raised $300M in Series B financing led by Various. AI multi-modal drug discovery and development platform. The new capital is framed around Advance 4 clinical programs and expand data partnerships with health systems.
What it does
AI multi-modal drug discovery and development platform. The business sits in Healthcare & Life Sciences, where funded companies are using fresh capital to deepen product coverage, distribution, or operating capacity.
Traction
AI integrates genomics, imaging, and EHR data to identify novel drug targets. Management framed the new capital around Advance 4 clinical programs and expand data partnerships with health systems.
Trend impact
AI drug discovery using patient data competing with Recursion. The capital raise matters because it gives the company more room to compete for customers, talent, and mindshare while incumbents and adjacent startups respond with clearer product depth or distribution.
Funding history
- January 1, 2022 · Series B · $300 million · Various
Products & services
- Healthcare & Life Sciences workflow monitoring tied to the funding announcement
- Customer-facing product described on the company website
- Operational tooling for healthcare & life sciences teams
- Data capture and reporting across core business processes
- Team expansion support funded by the latest round